Espositori 2019


Medifarmagen

Biomolecular screening of epigenetic biomarkers (microRNA) up or under regulated in people with respiratory disease respect to health people. In particular BREATHLESS will be be used from preventive medicine and job medicine as early diagnosis for respiratory diseases in people exposed to air pollutants, while BIXBIS will be used from physician of patients to obtain an early differential diagnosis using sputum between bacterial or viral of infection of airways.
Italy


Medifarmagen

Luca Gallelli, Erika Cione, Maria Cristina Caroleo, Roberto Cannataro, Domenico Apa

1997: First honour degree in Medicine and Surgery, University of Reggio Calabria
2000: Grant for foreign country stay by SIF (Italian Society of Pharmacology)
2001: PhD in Pharmacology and Toxicology (Chemotherapy) in Second University of Naples
2005: Specialist in Clinical Pharmacology, School of Medicine University of Catanzaro
From December 2005 to June 2006 collaboration as Attending Physician in Clinical Pharmacology Unit, Mater Domini Hospital, Catanzaro, Italy
2007: Assistant Professor in Pharmacology, Department of Health Science, School of Medicine, University of Catanzaro, Italy
2007: Attending Physician in Clinical Pharmacology Unit, Mater Domini Hospital, Catanzaro, Italy
2007-2011: Teaching in Pharmacology for student in nurse and medicine.
2007-2011: Teaching in Pharmacology for the Specialization in Pharmacology, Respiratory Medicine and Forensic Medicine.
from 2008 to 2014 member of auditor of Accounts, Order of Physicians of Catanzaro
2010-2011: Teaching in Pharmacology for the Master in Forensic Medicine
2011/2012 In Tech Scientific Board members
from 30/12/2012 to 30/06/2014 member of Ethic Committee of Vibo Valentia Hospital (Italy) as Clinical pharmacologist
from 02/03/2013 to 30/06/2014 member of Ethic Committee of Crotone Hospital (Italy) as Clinical pharmacologist
from 01/06/2013 to date member of II Clinical Commission for the evaluation of civil disability ASP Catanzaro
for 2014 to date President “auditor of Accounts”, Order of Physicians of Catanzaro
from 26 March 2014 to date Member of the editorial board of SIF “Drugs in evidence”.
from 01/01/2015 to date board member of Italian Association Board Multidisciplinary Respiratory (AIMAR) – now named as Italian Respiratory Society (SIP/IRS) - Calabria (Italy)
from 01/01/2015 to date Chief of the Study Group on “Drug interactions in respiratory diseases” of Italian Society of Pneumology (SIP) -Section of Calabria
from April 2016 to date member of GalaScreen Ltd. (G-Screen), Spin-off of the University of Calabria in charge of research and development in biotechnology;
from 02/05/2016 to date Chief of the Study Group on “antibiotic resistance and appropriate prescription in airway disease” of Italian Society of General Practitioners (SIMG) - Section Calabria
2016 Grant Horizon2020 SME Instrument
From 14/07/2016 to date Award Start Cup Calabria with the project “BixBis” for rapid diagnosis of airway infections and in the same day special award “Rubino” for the most innovative project.
02/12/2016 to date Award special mention “equal opportunities” obtained from Politecnico of Milan for the project BixBis during the Nation Award of Innovation.
02/12/2017 to date National Innovation Award with the project “RYGOLDZIP”
from 30/09/2016 to date Member and scientific chief of “Calabria Delegation of the International Foundation for Research on Rare Diseases”
From 04/12/2018 to date CEO and cofounder of Medifarmagen SRL, Spin off of University of Catanzaro
From 01/01/2019 to date Chief of Regional Section (Calabria) of Italian Respiratory Society


  A17 (pav. 7) - University of catanzaro
 2019

Back
 
Dati aggiornati il 19/10/2021 - 16.19.56